Merck & Company Incorporated
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 26.23 |
| 52 Week High | 61.62 |
| 52 Week Low | 23.64 |
| Avg. Daily Vol. (Mil) | 17.16 |
| Beta (3 year) | 1.32 |
| Share Related Items | |
| Mkt Cap (Mil) | 56,197.09 |
| Shares Out (Mil) | 2,142.47 |
| Float (Mil) | 2,141.74 |
| Dividend Information | |
| Yield % | 5.80 |
| Annual Dividend | 1.52 |
| Payout Ratio | 66.00 |
| Financial Strength | |
| Quick Ratio | 1.40 |
| Current Ratio | 1.80 |
| LT Debt/ Equity | 0.19 |
| Total Debt / Equity | 0.25 |
| Valuation Ratios | |
| Price Earnings | 11.50 |
| Price/Sales | 2.32 |
| Price/Book | 2.78 |
| Price/Cash Flow | 8.40 |
| Per Share Data | |
| Earnings | 2.29 |
| Sales | 11.29 |
| Book Value | 9.45 |
| Cash Flow | 3.14 |
| Business Summary | |
|---|---|
| A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. | |
| General Information | |
| One Merck Drive
P. O. Box 100 Whitehouse Station, NJ 08889-0100 |
|
| www.merck.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 59800 | |
| CEO: Richard T. Clark | |
| Short Interest | |
| Current Month (Mil) | 20.54 |
| Previous Month (Mil) | 20.77 |
| Short Interest Ratio (Days) | 1.60 |
| Management Effectiveness | |
| Return on Equity | 24.50 |
| Return on Assets | 10.50 |
| Return on Investments | 20.50 |
| Profitability | |
| Gross Margin | 83.70 |
| EBIT Margin | 23.90 |
| Profit Margin | 20.50 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas